10.89.A - Production of dietary supplements
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.12.Z - Other non-specialized retail trade
47.73.Z - Retail sale of pharmaceutical products
59.11.Z - Activities related to the production of films, video recordings, and television programs
60.39.Z - Other content distribution activities
73.11.Z - Advertising agency activities
86.22.Z - Specialist medical practice
86.95.Z - Physiotherapy activities
93.13.Z - Fitness club activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 11,9 | 2,4 | 55,1 | 2205,8 |
EBITDA | 13,7 | 2,4 | 53,7 | 2132,1 |
Short time liabilities | 4 | 6,7 | 6,6 | -2,1 |
Equity capital | 64,5 | 84,2 | 139,2 | 65,3 |
Operating profit (EBIT) | 11,9 | 2,3 | 51,8 | 2196,2 |
Assets | 69,7 | 92,1 | 146,9 | 59,6 |
Net profit (loss) | 9,6 | 2,4 | 55 | 2214 |
Cash | 23,2 | 42,4 | 90,4 | 113 |
Net income from sale | 83,5 | 12,5 | 183,2 | 1370,4 |
Liabilities and provisions for liabilities | 5,2 | 7,9 | 7,8 | -1,8 |
Working assets | 38,6 | 61,8 | 110,4 | 78,6 |
Depreciation | 1,7 | 0,2 | 2 | 1185,1 |
% | % | % | p.p. | |
Profitability of capital | 14,9 | 2,8 | 39,5 | 36,7 |
Equity capital to total assets | 92,6 | 91,4 | 94,7 | 3,3 |
Gross profit margin | 14,2 | 19,2 | 30,1 | 10,9 |
EBITDA Margin | 16,4 | 19,3 | 29,3 | 10 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 17 | 196 | 13 | -183 |
Current financial liquidity indicator | 8.654132843017578 | 15.763527870178223 | 7,1 | |
Net dept to EBITDA | -17.322263717651367 | -1.6686139106750488 | 15,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane